Tumor BoardsTumor Boards

Non-small cell lung cancer

Imaging


tumor board image
9/15/09: new metastatic EGFR L858R mutated NSCLC, treated with erlotinib

 

tumor board image
1/31/12: progressive disease now with acquired EGFR T790M mutation,
tumor board image
treated with afatinib followed by afatinib+cetuximab

tumor board image
1/31/15: stable disease with acquired EGFR T790M mutation, continued on afatinib+cetuximab
tumor board image
10/15/15: progressive disease with maintained EGFR T790M mutation, treated with osimertinib

tumor board image
6/13/16: progressive disease with loss of EGFR T790M but maintained L858R mutation, treated with erlotinib
tumor board image
8/5/16: progressive disease, enrolled in hospice